Get the App
A

Adaptimmune (ADAP)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Adaptimmune (ADAP)

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more

  • USD1.11
  • USD1.14
  • USD1.10
  • USD2.65
  • -35.30%
  • 22M
  • 306.39k
  • 940.52k
  • 182M
  • 1.01
  • -49.80%

Stock News

Inside Foot Locker CEO's plan to run a better business

34 minutes ago

Inside Foot Locker CEO's plan to run a better business

Yahoo

Allegion to Host 2023 ‘Investor & Analyst Day’

1 hour ago

Allegion to Host 2023 ‘Investor & Analyst Day’

Yahoo

Virgin Orbit extends unpaid pause as Brown deal collapses, 'dynamic' talks continue

1 hour ago

Virgin Orbit extends unpaid pause as Brown deal collapses, 'dynamic' talks continue

CNBC

Top Stocks for April 2023

1 hour ago

Top Stocks for April 2023

Yahoo

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium